A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice

British Journal of Pharmacology

Volumn 144, Issue 2, 2005, Pages 231-241

  Escobedo, Isabel ^a   O'Shea, Esther ^a   Orio, Laura ^a   Sanchez, Veronica ^a   Segura, Mireia ^b   De La Torre, Rafael ^b,c   Farre, Magi ^b,d   Green, Alfred Richard ^e   Colado, Maria Isabel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

5 HT; Dopamine; HHMA; Intrastriatal administration; MDMA; MDMA metabolism; Mice; Neurotoxicity; Temperature

Indexed keywords

3,4 DIHYDROXYMETHAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; METHAMPHETAMINE; MONOAMINE DERIVATIVE; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD LEVEL; BRAIN; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; HYPERTHERMIA; MALE; METABOLITE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RECTUM TEMPERATURE; SEROTONIN BRAIN LEVEL;

ANIMALS; BIOGENIC MONOAMINES; BRAIN; CORPUS STRIATUM; DEOXYEPINEPHRINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED C57BL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; TIME FACTORS;

EID: 13444269027     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706071     Document Type: Article

References (33)

1. BALDWIN, H.A., WILLIAMS, J.L., SNARES, M., FERREIRA, T., CROSS, A.J. & GREEN, A.R. (1994). Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischaemia in the cerebral cortex of the rat. Br. J. Pharmacol., 112, 188-194.
2. BUCHERT, R., THOMASIUS, R., NEBELING, B., PETERSEN, K., OBROCKI, J., JENICKE, L., WILKE, F., WARTBERG, L., ZAPLETALOVA, P. & CLAUSEN, M. (2003). Long-term effects of 'ecstasy' use on serotonin transporters of the brain investigated by PET. J. Nucl. Med., 44, 375-384.
3. CAMARERO, J., SANCHEZ, V., O'SHEA, E., GREEN, A.R. & COLADO, M.I. (2002). Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxy-methamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum. J. Neurochem., 81, 961-972.
4. CHO, A.K., HIRAMATSU, M., DISTEFANO, E.W., CHANG, A.S. & JENDEN, D.J. (1990). Stereochemical differences in the metabolism of 3,4- methylenedioxymethamphetamine in vitro and in vivo: a pharmacokinetic analysis. Drug Metab. Disposition, 18, 686-691.
5. COLADO, M.I., CAMARERO, J., MECHAN, A.O., SANCHEZ, V., ESTEBAN, B., ELLIOTT, J.M. & GREEN, A.R. (2001). A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain. Br. J. Pharmacol., 134, 1711-1723.
6. COLADO, M.I., O'SHEA, E., GRANADOS, R., MURRAY, T.K. & GREEN, A.R. (1997). In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine. Br. J. Pharmacol., 121, 889-900.
7. ESTEBAN, B., O'SHEA, E., CAMARERO, J., SANCHEZ, V., GREEN, A.R. & COLADO, M.I. (2001). 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology, 154, 251-260.
8. GREEN, A.R., MECHAN, A.O., ELLIOTT, J.M., O'SHEA, E. & COLADO, M.I. (2003). The pharmacology and clinical pharmacology of 3,4- methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacol. Rev., 55, 463-508.
9. HEWITT, K.E. & GREEN, A.R. (1994). Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats. Neuropharmacology, 33, 1589-1595.
10. JOHNSON, M., ELAYAN, I., HANSON, G.R., FOLTZ, R.L., GIBB, J.W. & LIM, H.K. (1992). Effects of 3,4-dihydroxymethamphetamine and 2,4,5- trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems. J. Pharmacol. Exp. Ther., 261, 337-453.
11. KLUGER, M.J. (1991). Fever: role of pyrogens and cryogens. Physiol. Rev., 71, 93-127.
12. KÖNIG, J.F.R. & KLIPPEL, R.A. (1963). The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem. New York: Robert E Krieger Publishing Co. Inc.
13. LIM, H.K. & FOLTZ, R.L. (1988). In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector. Chem. Res. Toxicol., 1, 370-378.
14. LOGAN, B.J., LAVERTY, R., SANDERSON, W.D. & YEE, Y.B. (1988). Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity. Eur. J. Pharmacol., 152, 227-234.
15. MANN, H., LADENHEIM, B., HIRATA, H., MORAN, T.H. & CADET, J.L. (1997). Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice. Brain Res., 769, 340-346.
16. MCCANN, U.D., SZABO, Z., SCHEFFEL, U., DANNALS, R.F. & RICAURTE, G.A. (1998). Positron emission tomographic evidence of toxic effect of MDMA ('Ecstasy') on brain serotonin neurons in human beings. Lancet, 352, 1433-1437.
17. MECHAN, A.O., ESTEBAN, B., O'SHEA, E., ELLIOTT, J.M., COLADO, M.I. & GREEN, A.R. (2002). The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. Br. J. Pharmacol., 135, 170-180.
18. O'CALLAGHAN, J.P. & MILLER, D.B. (1994). Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther., 270, 741-751.
19. O'SHEA, E., EASTON, N., FRY, J.R., GREEN, A.R. & MARSDEN, C.A. (2002). Protection against 3,4-methylenedioxymethamphetamine-induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia. J. Neurochem., 81, 686-695.
20. O'SHEA, E., ESTEBAN, B., CAMARERO, J., GREEN, A.R. & COLADO, M.I. (2001). Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain. Neuropharmacology, 40, 65-74.
21. ORIO, L., O'SHEA, E., SANCHEZ, V., PRADILLO, J.M., ESCOBEDO, I., CAMARERO, J., MORO, M.A., GREEN, A.R. & COLADO, M.I. (2004). 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion. J. Neurochem., 89, 1445-1453.
22. PIZARRO, N., DE LA TORRE, R., FARRE, M., SEGURA, J., LLEBARIA, A. & JOGLAR, J. (2002a). Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites. Bioorg. Med. Chem., 10, 1085-1092.
23. PIZARRO, N., ORTUNO, J., FARRE, M., HERNANDEZ-LOPEZ, C., PUJADAS, M., LLEBARIA, A., JOGLAR, J., ROSET, P.N., MAS, M., SEGURA, J., CAMI, J. & DE LA TORRE, R. (2002b). Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis. J. Anal. Toxicol., 26, 157-165.
24. RENEMAN, L., BOOIJ, J., DE BRUIN, K., REITSMA, J.B., DE WOLFF, F.A., GUNNING, W.B., DEN HEETEN, G.J. & VAN DEN BRINK, W. (2001). Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet, 358, 1864-1869.
25. SAADAT, K.S., ELLIOTT, J.M., COLADO, M.I. & GREEN, A.R. (2004). Hyperthermic and neurotoxic effect of 3,4-methylenedioxymethamphetamine (MDMA) in guinea pigs. Psychopharmacology, 173, 452-453.
26. SANCHEZ, V., CAMARERO, J., ESTEBAN, B., PETER, M.J., GREEN, A.R. & COLADO, M.I. (2001). The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain. Br. J. Pharmacol., 134, 46-57.
27. SCHMUED, L.C. (2003). Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA. Brain Res., 974, 127-133.
28. SEGURA, M., ORTUNO, J., FARRE, M., MCLURE, J.A., PUJADAS, M., PIZARRO, N., LLEBARIA, A., JOGLAR, J., ROSET, P.N., SEGURA, J. & DE LA TORRE, R. (2001). 3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans. Chem. Res. Toxicol., 14, 1203-1208.
29. SHARKEY, J., MCBEAN, D.E. & KELLY, P.A. (1991). Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ('Ecstasy'). Psychopharmacology, 105, 113-118.
30. STEPHENSON, C.P., HUNT, G.E., TOPPLE, A.N. & MCGREGOR, I.S. (1999). The distribution of 3,4-methylenedioxymethamphetamine 'Ecstasy'-induced c-fos expression in rat brain. Neuroscience, 92, 1011-1023.
31. STONE, D.M., HANSON, G.R. & GIBB, J.W. (1987). Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats. Neuropharmacology, 26, 1657-1661.
32. THOMASIUS, R., PETERSEN, K., BUCHERT, R., ANDRESEN, B., ZAPLETALOVA, P., WARTBERG, L., NEBELING, B. & SCHMOLDT, A. (2003). Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology, 167, 85-96.
33. TUCKER, G.T., LENNARD, M.S., ELLIS, S.W., WOODS, H.F., CHO, A.K., LIN, L.Y., HIRATSUKA, A., SCHMITZ, D.A. & CHU, T.Y. (1994). The demethylenation of methylenedioxymethamphetamine ('ecstasy') by debrisoquine hydroxylase (CYP2D6). Biochem. Pharmacol., 47, 1151-1156.